Keystone Symposia on Host and the Environment in IBD_Scientific Advances Leading to New Therapeutics

Event Information

Meeting Type: Physical
Meeting Website: http://www.keystonesymposia.org/19A2
Dates: January 13 - 17, 2019
Location: Taos, New Mexico , United States
Intended Audience: Basic Scientist, Clinical Scientist, Early Career, In Training, Media, Physician or Advanced Practice Professional
Sponsor: Keystone Symposia on Molecular and Cellular Biology
Purpose: Education, Scientific
Number of CME Credits Offered: None

Topics: Endocrine Disruption, Endocrine Genetics, General Endocrine Practice

Description: The inflammatory bowel diseases (IBD), which afflict millions of patients, are rapidly increasing in incidence world-wide in parallel with industrialization. Pathogenesis involves both host genetic as well environmental factors where the most currently utilized therapeutics focus on long-term host immunosuppression. Despite tremendous advances in our understanding of IBD genetics, the mucosal immune system, and environmental factors such as the gut microbiome, currently available therapeutic modalities for IBD remain suboptimal. The overall goal of this meeting is to bring together world-class investigators and clinicians to discuss the latest scientific knowledge relevant to the pathogenesis of IBD to facilitate an interactive discussion about paradigms that will facilitate the accelerated development of new opportunities to prevent and/or treat IBD. The specific aims of this meeting are: 1. To bring together a combination of clinical and basic investigators in both academia and industry to facilitate cross-disciplinary discussions focused on IBD. 2. To identify both the opportunities and gaps in current knowledge in the pathogenesis of IBD important in the development of new diagnostics and therapeutics for IBD. 3. To create a multidisciplinary environment that will inspire both young and established investigators by highlighting the currently available opportunities in research focused on the field of IBD. The anticipated outcome of this meeting will be a better understanding of the advances, and the challenges, in the current field that will lead to new therapies for patients with IBD.

Event Contact

Name: Attendee Services
Email: info@keystonesymposia.org
Phone: 970.262.1230 or 800-2530685
Fax: 970-262-1525